These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 41560)

  • 1. Pharmacokinetics of the new beta-adrenoceptor blocker SL 75212 in man after repeated oral administration [proceedings].
    Bianchetti G; Blatrix C; Gomeni R; Kilborn JR; Larribaud J; Lücker PW; Morselli PL; Thébault JJ; Trocherie S
    Br J Clin Pharmacol; 1979 Oct; 8(4):408P. PubMed ID: 41560
    [No Abstract]   [Full Text] [Related]  

  • 2. Pharmacokinetics of the new beta-adrenoceptor blocking agent betaxolol (SL 75212) in man after repeated oral administration.
    Bianchetti G; Blatrix C; Gomeni R; Kilborn JR; Larribaud J; Lücker PW; Thebault JJ; Trocherie S; Morselli PL
    Arzneimittelforschung; 1980; 30(11):1912-6. PubMed ID: 6109538
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of the beta-adrenoceptor blocking properties and pharmacokinetics of SL 75212 and propranolol in man [proceedings].
    Bianchetti G; Chauvin M; Giudicelli JF; Gomeni R; Kilborn JR; Morselli PL; Richer C; Thuillez C
    Br J Clin Pharmacol; 1979 Oct; 8(4):407P-708P. PubMed ID: 41559
    [No Abstract]   [Full Text] [Related]  

  • 4. [The pharmacokinetics of 1-(4-cyclohexylureidophenoxy)-2-hydroxy-3-tert-butylaminopropane (talinolol, Cordanum, 02-115) 2. Excretion, blood level and distribution of the 14C-labeled compound in the rat].
    Klemm W; Wenzel A
    Pharmazie; 1975 Oct; 30(10):675-7. PubMed ID: 695
    [No Abstract]   [Full Text] [Related]  

  • 5. Pharmacokinetics of betaxolol in middle aged patients.
    Bianchetti G; Thiercelin JF; Thenot JP
    Eur J Clin Pharmacol; 1986; 31(2):231-3. PubMed ID: 2879735
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacokinetics of butofilolol (CAFIDE) after repeated oral administration in man.
    Houin G; Barre J; Jeanniot JP; Ledudal P; Cautreels W; Tillement JP
    Int J Clin Pharmacol Res; 1984; 4(3):175-83. PubMed ID: 6149195
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of a meal and its composition on the bioavailability of betaxolol administered orally to healthy subjects.
    Thiercelin JF; Bianchetti G; Larribaud J; Ganansia J; Deves C; Trocherie S; Abriol C; Morselli PL
    World Rev Nutr Diet; 1984; 43():183-6. PubMed ID: 6147938
    [No Abstract]   [Full Text] [Related]  

  • 8. Pharmacokinetics of flestolol in man: preliminary data.
    Achari R; Hulse JD; Drissel D; Matier WL
    Br J Clin Pharmacol; 1985 Dec; 20(6):691-4. PubMed ID: 2868745
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacokinetics of nadolol, a beta-receptor antagonist: administration of therapeutic single- and multiple-dosage regimens to hypertensive patients.
    Dreyfuss J; Griffith DL; Singhvi SM; Shaw JM; Ross JJ; Vukovich RA; Willard DA
    J Clin Pharmacol; 1979; 19(11-12):712-20. PubMed ID: 43870
    [No Abstract]   [Full Text] [Related]  

  • 10. Blood concentrations and pharmacodynamic effects of SL 75212, a new beta-adrenoceptor antagonist, after oral and intravenous administration [proceedings].
    Bianchetti G; Gomeni R; Kilborn JR; Morselli PL; Taylor EA; Warrington SJ
    Br J Clin Pharmacol; 1979 Oct; 8(4):403P-404P. PubMed ID: 41556
    [No Abstract]   [Full Text] [Related]  

  • 11. Pharmacokinetics of single and multiple doses of flusoxolol (Ro 31-1411) in healthy subjects.
    Gillies HC; Rogers HJ; Francis RJ; Galloway DB; Humphreys JE
    Eur J Clin Pharmacol; 1986; 31(1):113-5. PubMed ID: 2877883
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Basic pharmacokinetics of bisoprolol, a new highly beta 1-selective adrenoceptor antagonist.
    Leopold G; Pabst J; Ungethüm W; Bühring KU
    J Clin Pharmacol; 1986; 26(8):616-21. PubMed ID: 2878941
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The spectrofluorimetric estimation and buccal absorption of SL 75212, a novel beta-adrenoceptor antagonist [proceedings].
    Davis BJ; Turner P
    Br J Clin Pharmacol; 1979 Oct; 8(4):405P. PubMed ID: 41558
    [No Abstract]   [Full Text] [Related]  

  • 14. Pharmacokinetics and metabolism of a new beta-adrenergic blocking agent, the 1, ter-butyl-amino-3-(1,2,3,4-tetrahydro-1,4-ethano-8-hydroxy-5-naphthoxy)-2-propanol (K 5407).
    Goldaniga G; Montesanti L; Pianezzola E; Valzelli G
    Eur J Drug Metab Pharmacokinet; 1980; 5(1):9-20. PubMed ID: 6104601
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacokinetics of SL 75212 and propranolol in old age, uraemia and in healthy young adults [proceedings].
    Bianchetti G; Brancaccio D; Forette F; Henry JF; Hervy MP; Ganansia J; Gomeni R; Kilborn JR; Morselli PL
    Br J Clin Pharmacol; 1980 Mar; 9(3):299P. PubMed ID: 6102472
    [No Abstract]   [Full Text] [Related]  

  • 16. Pharmacokinetics and biopharmaceutics of some adrenergic beta-receptor antagonists with special emphasis on alprenolol and metoprolol.
    Regårdh CG
    Acta Pharmacol Toxicol (Copenh); 1975; 37(1):1-39. PubMed ID: 237402
    [No Abstract]   [Full Text] [Related]  

  • 17. [Comparative pharmacokinetics of the beta-1 receptor blookader celiprolol after a single oral administration in subjects with health kidneys and in patients with impaired renal function].
    Schmidt P; Takacs F; Pittner H; Minar E; Balcke P; Zazgornik J; Deutsch E
    Wien Klin Wochenschr; 1985 Sep; 97(18):729-32. PubMed ID: 2866633
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacokinetics of adimolol after single and multiple dose administration in healthy volunteers.
    Wiedemann I; Peil H; Justus H; Adamus S; Brantl V; Lohmann H
    Arzneimittelforschung; 1985; 35(6):964-9. PubMed ID: 2862877
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Metabolic studies in patients with nadolol: oral and intravenous administration.
    Dreyfuss J; Brannick LJ; Vukovich RA; Shaw JM; Willard DA
    J Clin Pharmacol; 1977; 17(5-6):300-7. PubMed ID: 16040
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tissue distribution of exaprolol in rat.
    Faberová V; Trnovec T; Zemánek M; Bezek S; Durisová M; Tomcíková O
    Eur J Drug Metab Pharmacokinet; 1985; 10(1):11-3. PubMed ID: 2863149
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.